Alkem Laboratories responds to NSE query regarding XBRL financial results submission for March 2025 quarter.
Company acknowledges discrepancy in labeling financial results as 'audited' in XBRL filing.
Alkem submits revised standalone and consolidated XBRL filings to correct the discrepancy.
Compliance officer Manish Narang officially signs and submits the clarification response.